Skip to content

Influence of Functional Electrical Stimulation (FES) on Neurogenic Foot Drop in Adolescent and Adult Patients with Infantile Cerebral Palsy

Influence of Functional Electrical Stimulation (FES) on Neurogenic Foot Drop in Adolescent and Adult Patients with Infantile Cerebral Palsy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00034470
Enrollment
10
Registered
2024-06-19
Start date
2017-04-10
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile Cerebral Palsy G80

Interventions

Group 1: Evaluation of Clinical and Dynamic Data in adult and adolescent patients with infantile cerebral palsy at the initiation of FES treatment and after three months of everyday use.

Sponsors

Universitätsklinikum Heidelberg; Klinik für Orthopädie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 70 Years

Inclusion criteria

Inclusion criteria: - Gross Motor Function Classification System (GMFCS) levels I to III. - Neurogenic equinus deformity up to a maximum of 5 degrees in knee extension. - Walking distance > 10 meters without aids. - Compliance: Adherence to treatment protocols. - Muscle strength grade (Tibialis anterior) < 4. - Knee flexion contracture < 10 degrees. - Hip flexion contracture < 20 degrees.

Exclusion criteria

Exclusion criteria: - Patient is 16 years old or younger. - Surgery or botulinum toxin injection in the lower extremities within the last 6 months. - Presence of: knee endoprosthesis, pacemaker, or other implanted electrical devices. - Pregnancy. - Epilepsy.

Design outcomes

Primary

MeasureTime frame
Changes in dynamic equinus deformity in instrumented 3D gait analysis with and without the FES system, determined at the time of study enrollment and after three months. Outcome measure: Range of motion of the ankle

Secondary

MeasureTime frame
Changes in spasticity in instrumented 3D gait analysis with and without the FES system, determined at the time of study enrollment and after three months. Outcome measure: EMG activity of the gastrocnemius muscle. 2. Satisfaction with Assistive Devices, QUEST Scores (Quebec User Evaluation of Satisfaction with Assistive Technology).

Countries

Germany

Contacts

Public ContactCornelia Putz

Universitätsklinikum Heidelberg; Klinik für Orthopädie

Cornelia.Putz@med.uni-heidelberg.de+49 6221 56-35434

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026